Rabeel Ahmad

Cooper University Hospital

Papers

1

Total Citations

3

H-Index

1

About

Rabeel Ahmad is a clinical researcher whose work focuses on advancing perioperative pain management and regional anesthesia, particularly in the context of robotic thoracic surgery. His most notable contribution is a 2024 randomized clinical trial comparing liposomal bupivacaine versus bupivacaine with dexamethasone for intercostal nerve blocks, a study that directly addresses the critical need for optimized postoperative analgesia in minimally invasive procedures. This work, already garnering early citations, demonstrates his commitment to evidence-based improvements in patient recovery and surgical outcomes. Ahmad’s research sits at the intersection of anesthesiology and surgical innovation, exploring how adjuvant therapies and drug formulations can enhance nerve block efficacy and duration. By rigorously evaluating these interventions, he provides actionable insights for clinicians seeking to reduce opioid reliance and improve pain scores after robotic surgery. With a growing citation footprint and a focus on high-impact clinical trials, Ahmad is establishing himself as a rising voice in the field of regional anesthesia and perioperative medicine, contributing valuable data that shapes modern pain management protocols.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Liposomal Bupivacaine Versus Bupivacaine and Dexamethasone Intercostal Nerve Blocks for Robotic Thoracic Surgery: A Randomized Clinical Trial
3 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Cooper University Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago